NO751208L - - Google Patents

Info

Publication number
NO751208L
NO751208L NO751208A NO751208A NO751208L NO 751208 L NO751208 L NO 751208L NO 751208 A NO751208 A NO 751208A NO 751208 A NO751208 A NO 751208A NO 751208 L NO751208 L NO 751208L
Authority
NO
Norway
Prior art keywords
alkyl
formula
atoms
hydrogen
methyl
Prior art date
Application number
NO751208A
Other languages
Norwegian (no)
Inventor
G Saucy
J W Scott
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO4629/69A external-priority patent/NO133806C/no
Publication of NO751208L publication Critical patent/NO751208L/no
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Description

Fremgangsmåte for fremstillingMethod of manufacture

av perhydrobenzindener.of perhydrobenzindenes.

Nærværende oppfinnelse vedrorer en fremgangsmåte for fremstilling av perhydrobenzindener,henholdsvis forbindelser av formel The present invention relates to a method for the production of perhydrobenzidenes, respectively compounds of the formula

hvor R betyr en primær alkylgruppe med 1-5 C-atomer, 2 3 R og R er like og betyr alkyl med 1-8 C-atomer eller en rest av begge hydrogen og den andre alkyl med 1-8 C-atomer, og Z er karbonyl, C-^g-alkylendioksy-metylen, di-C-^g-alkoksymetylen, fendioksy-metylen eller en gruppe av formelen where R means a primary alkyl group of 1-5 C atoms, 2 3 R and R are equal and means alkyl of 1-8 C atoms or a residue of both hydrogen and the other alkyl of 1-8 C atoms, and Z is carbonyl, C 1 -C 8 -alkylenedioxymethylene, di-C 1 -C 6 -alkylene dioxymethylene, phendioxymethylene or a group of the formula

hvor R 5 er hydrogen, C-^ g-alkyl, C1_g-alkoksy-C1_g- where R 5 is hydrogen, C 1-6 alkyl, C 1-6 alkoxy-C 1-6

alkyl, fenyl-C-^ g-alkyl, tetrahydropyranyl eller en acylrest av en C1. —o0-monokarboksyl'syre, R^ hydrogen eller en alifatisk hydrokarbongruppe med 1-8 C-ato- alkyl, phenyl-C1-6 alkyl, tetrahydropyranyl or an acyl residue of a C1. —o0-monocarboxylic' acid, R^ hydrogen or an aliphatic hydrocarbon group with 1-8 C-ato-

mer og m er 1 eller 2.more and m is 1 or 2.

Det i beskrivelsen og krav anvendte uttrykk "hydrokarbonrest" betegner en 1-verdig substituent som bare består av karbon og|hydrogenatomer. Uttrykket "alifatisk" i relasjon til hydro-karbonrester betegner såvel mettede som umettede grupper, f. The term "hydrocarbon residue" used in the description and claims denotes a 1-valent substituent which consists only of carbon and hydrogen atoms. The term "aliphatic" in relation to hydrocarbon residues denotes both saturated and unsaturated groups, e.g.

eks. alkyl- eller alkylengrupper eller tilsvarende rester med olefinisk eller acetylenisk dobbeltbinding. Uttrykket "alkyl" betegner såvel rettkjedete som forgrenede mettede hydrokarbon-rester. Uttrykket "primær alkylgruppe" betegner en alkylrest hvis frie valens går ut fra et karbonatom med minst 2 hydrogenatomer . e.g. alkyl or alkylene groups or corresponding residues with an olefinic or acetylenic double bond. The term "alkyl" denotes both straight-chain and branched saturated hydrocarbon residues. The term "primary alkyl group" denotes an alkyl residue whose free valence starts from a carbon atom with at least 2 hydrogen atoms.

Eksempler på alkyl, alkenyl, alkylen eller alkinyl er metyl, etyl, butyl, tert.-butyl, heksyl, 2-etylheksyl, vinyl, butenyl, heksenyl, etylen, metylen, og etinyl, formyl, acetyl, benzoyl Examples of alkyl, alkenyl, alkylene or alkynyl are methyl, ethyl, butyl, tert.-butyl, hexyl, 2-ethylhexyl, vinyl, butenyl, hexenyl, ethylene, methylene, and ethynyl, formyl, acetyl, benzoyl

er eksempler på acylrester av monokarboksylsyrer, 2-fenyletyl for en fenylalkylrest, metoksymetyl, 1-metoksyetyl eller 2-metoksyetyl for alkoksyalkyl og metoksy, etoksy eller tert.-but-oksy for alkoksygrupper . are examples of acyl residues of monocarboxylic acids, 2-phenylethyl for a phenylalkyl residue, methoxymethyl, 1-methoxyethyl or 2-methoxyethyl for alkoxyalkyl and methoxy, ethoxy or tert.-butoxy for alkoxy groups.

I den anvendte strukturformler befinner de forskjellige sub-stituenter i ringskjelettet seg enten i o-stilling,karakterisert veden punktert linje ( ), i (3-stilling,karakterisert veden rett linje ( ) eller deres stilling er ikke noyaktig fastlagt,karakterisert veden bolgelinje (^-^^-^-) , d.v.s. de kan befinne seg i a-eller (3-stilling. Strukturform-lene gjengir forbindelsene i form av racemater med den unntagelse at substituenten R vilkårlig ble tilordnet (3-stillin-gen. In the structural formulas used, the various substituents in the ring skeleton are either in the o-position, characterized by a dotted line ( ), in the (3-position, characterized by a straight line ( ) or their position is not precisely determined, characterized by a wavy line ( ^-^^-^-), i.e. they can be in the a- or (3-position. The structural formulas reproduce the compounds in the form of racemates with the exception that the substituent R was arbitrarily assigned to the (3-position.

Fremgangsmåten ifolge oppfinnelsen karakteriseres ved at man hydrogenerer en forbindelse av formel i nærvær av en edelmetallkatalysator, i noytralt, surt eller svakt basisk miljo. The method according to the invention is characterized by hydrogenating a compound of formula in the presence of a noble metal catalyst, in a neutral, acidic or weakly basic environment.

Hydrogeneringen gjennomfores fortrinnsvis i en lavere alkohol, som opplosningsmiddel, f.eks. i etanol, fortrinnsvis under an-vendelse av en palladiumkatalysator på kull som bærematériale. Den kan videre gjennomfores i det vesentlige ved romtemperatur og under normaltrykk, slik at selektiv hydrogener ing av /^^ °^-bindigen, uten hydrogenering av isoksazolylresten, finner sted. Egnede svake baser er mono-, di- eller tri-lavere-alkylaminer, fortrinnsvis trietylamin. Det har vist seg at ved anvendelsen av en base forloper hydrogeneringen stereospesifikt, og man får med utgang fra trans-anti-enoner av formelen II forbindelser av formelen I med trans-anti-trans-konfigurasjon. Med utgang fra en forbindelse av formel II, hvor R er i (3-stilling og de til karbonatomene 8 og 14 (steroidnummerering) bundne hydrogenatomer befinner seg i (3- henh. a-stilling, får man altså forbindelser av formel I med et hydrogenatom i 9a-stilling. The hydrogenation is preferably carried out in a lower alcohol, as a solvent, e.g. in ethanol, preferably using a palladium catalyst on coal as carrier material. It can further be carried out essentially at room temperature and under normal pressure, so that selective hydrogenation of the /^^ °^-ligand, without hydrogenation of the isoxazolyl residue, takes place. Suitable weak bases are mono-, di- or tri-lower alkylamines, preferably triethylamine. It has been shown that when a base is used, the hydrogenation proceeds stereospecifically, and starting from trans-anti-enones of the formula II, compounds of the formula I with a trans-anti-trans configuration are obtained. Starting from a compound of formula II, where R is in the (3-position) and the hydrogen atoms bound to carbon atoms 8 and 14 (steroid numbering) are in the (3- according to a-position), one thus obtains compounds of formula I with a hydrogen atom in the 9a position.

Forbindelsene av formel I ifolge oppfinnelsen er verdifulle mellomprodukter ved fremstillingen av farmakologisk virksomme steroider, f.eks. slike av formlen The compounds of formula I according to the invention are valuable intermediates in the production of pharmacologically active steroids, e.g. such of the formula

hvor R og Z har foran angitte betydninger, og R 4 er hydrogen eller en C-, --alkylrest med en CH9-2 3 where R and Z have the above meanings, and R 4 is hydrogen or a C-, --alkyl radical with a CH9-2 3

gruppe mindre enn R eller R .group less than R or R .

Forbindelsen av formel III, hvor Z er karbonyl, R<-1>etyl og II m 1 (19-nor-18-homo-androst-4-en-3,17-dion) kan etinyleres selektivt ved hjelp av en egnet metall-organisk acetylenfor-bindelse til norgestrel (13p-etyl-17-a-etinyl-17-hydroksy-gon-4-en-3-on). Norgestrel er en kjent progestativt virksom forbindelse. Eksempler på egnede etinyleringsmidler er alkali-metall-acetylider som litium-, natrium- og kaliumacetylid. Reaksjonen gjennomfores i et egnet opplosningsmiddel som benzen eller toluen i nærvær av flytende ammoniakk, i et tempera-turområde mellom -60° og -30°C, fortrinnsvis ved reaksjons-mediets tilbakelopstemperatur. Et eksempel på et ytterligere egnet etinyleringsmiddel er et litiumacetylid-diaminkompleks i dimetylformamid som opplosningsmiddel. The compound of formula III, where Z is carbonyl, R<-1>ethyl and II m 1 (19-nor-18-homo-androst-4-ene-3,17-dione) can be selectively ethynylated using a suitable metal -organic acetylene compound to norgestrel (13β-ethyl-17-α-ethynyl-17-hydroxygon-4-en-3-one). Norgestrel is a known progestatively active compound. Examples of suitable ethynylating agents are alkali metal acetylides such as lithium, sodium and potassium acetylide. The reaction is carried out in a suitable solvent such as benzene or toluene in the presence of liquid ammonia, in a temperature range between -60° and -30°C, preferably at the reflux temperature of the reaction medium. An example of a further suitable ethynylating agent is a lithium acetylide-diamine complex in dimethylformamide as solvent.

Forbindelser av formel III, hvor Z er karbonyl, kan overfores til de tilsvarende farmasoytisk verdifulle pregnaner, d.v.s. til forbindelser av formel III, hvor Z er en rest av formelen Compounds of formula III, where Z is carbonyl, can be converted to the corresponding pharmaceutically valuable pregnanes, i.e. to compounds of formula III, where Z is a residue of the formula

etter i og for seg kjent metoder. Ved overforingen av andro-stan-17-oner til tilsvarende pregnaner skal alle karbonylgrupper med unntagelse av den i 17-stilling forst overfores til be-skyttet form. 19-nor-androst-4-en-3,17-dion kan f.eks. overfores til 19-nor-progesteren. according to per se known methods. In the conversion of andro-stan-17-ones to corresponding pregnanes, all carbonyl groups with the exception of the one in the 17-position must first be converted to a protected form. 19-nor-androst-4-ene-3,17-dione can e.g. transferred to the 19-nor progesteren.

19-nor-forbindelser av formel III, hvor R"<*>" er propyl, er ovulasjonsinhibitorer. Endelig er en forbindelse av formel III, hvor R^" er metyl og Z karbonyl, blitt overfort til 19-nor-testosteron-acetat [j.Org.Chem., 26, 3904 (1961), L.J. Chinn et al.]. 19-nor compounds of formula III, where R"<*>" is propyl, are ovulation inhibitors. Finally, a compound of formula III, where R^" is methyl and Z is carbonyl, has been converted to 19-nor-testosterone acetate [j.Org.Chem., 26, 3904 (1961), L.J. Chinn et al.].

Fremstillingen av utgangsmaterialet av formel II såvel som overforingen av forbindelsene av formel I ifolge oppfinnelsen til steroider av formel III er f.eks. beskrevet i det belgi-ske patent nr. 7 4 2090. The production of the starting material of formula II as well as the conversion of the compounds of formula I according to the invention to steroids of formula III is e.g. described in the Belgian patent no. 7 4 2090.

I J In J

I IN

Hvis ikke uttrykkelig det motsatte er angitt vedrorer alle krav rettet på forbindelsene disse såvel i form av deres racemater som i form av deres optiske enantiomerer. If not expressly stated to the contrary, all claims directed to these compounds relate both in the form of their racemates and in the form of their optical enantiomers.

I de folgende eksempler, som forklarer oppfinnelsen, er alle temperaturer angitt i Celsius-grader. In the following examples, which explain the invention, all temperatures are given in degrees Celsius.

EKSEMPEL 1EXAMPLE 1

En blanding av 1,00 g racemisk trans-anti-6-[(3,5-dimetyl-isoksazol-4-yl)-metyl]-3a-mety1-3,7-diokso-l,2,3a,4,5,7,8,9, 9a,9b-dekahydro-3H-benz[ejinden, 60 mg palladium på kull (lo %) og 100 ml av en 3:1 blanding av etanol og trietylamin ble hydrogenert ved romtemperatur og under normaltrykk. I A mixture of 1.00 g of racemic trans-anti-6-[(3,5-dimethyl-isoxazol-4-yl)-methyl]-3a-methyl-3,7-dioxo-1,2,3a,4, 5,7,8,9,9a,9b-decahydro-3H-benz[ejinde, 60 mg of palladium on charcoal (lo%) and 100 ml of a 3:1 mixture of ethanol and triethylamine were hydrogenated at room temperature and under atmospheric pressure. IN

lopet av 1 time ble én ekvivalent hydrogen tatt opp. Hydro-generingsproduktet ble normalt ikke isolert. Unntagelsesvis ble imidlertid omkrystallisert etter fjerning av katalysatoren ved filtrering og av opplosningsmidlet fra benzen-heksan, og rent racemisk trans-anti-trans-anti-6-[(3,5-dimetyl-isoksazol-4-yl)-metyl]-3a-metyl-3,7-diokso-perhydro-benz[e]inden ble oppnådd i form av hvite prismer med smeltepunkt 137,5 - 139,5°. over the course of 1 hour, one equivalent of hydrogen was taken up. The hydrogenation product was not normally isolated. Exceptionally, however, after removal of the catalyst by filtration and of the solvent from benzene-hexane, pure racemic trans-anti-trans-anti-6-[(3,5-dimethyl-isoxazol-4-yl)-methyl]-3a was recrystallized -methyl-3,7-dioxo-perhydro-benz[e]indene was obtained in the form of white prisms with melting point 137.5 - 139.5°.

EKSEMPEL 2EXAMPLE 2

En opplosningav 1,308 g (+)-trans-anti-6-[(3,5-dimetylisoksa-zol-4-yl)-metyl]-3a-metyl-3,7-diokso-l,2,3a,4,5,7,8,9,9a,9b-dékahydro-3H-benz[e]inden i 100 ml av en 3:1 blanding av etanol og trietylamin ble hydrogenert ved romtemperatur og under normaltrykk i nærvær av 80 mg palladium på kull (10%). Hydrogenopptagelsen horte opp etter 1 1/2 time. Filtrering og fjerning av opplosningsmidlet ga trans-anti-trans-6-[(3,5- dimetyl-isoksazol-4-yl)-metyl]-3a-metyl-3,7-diokso-perhydro- ! benz[e]inden som farvelost skum. Dette råprodukt ble tatt opp i 10 ml etylenglykol og 7 5 ml petroleter (Benzin) og oppvarmet 20 timer med 7 50 mg p-toluensulfonsyre under tilbakelopskjoling og nitrogenatmosfære ved azeotrop fjerning av vann. Den avkjolte opplosning ble vasket med mettet, vandig natriumbikarbonatopplosning og koksaltopplosning, torket over vannfritt natriumsulfat og konsentrert og ga trans-anti-trans-3,3,7,7-bis-(ety-lendioksy)-6-[(3,5-dimetylisoksazol-4-yl)-metyl]-3a-metyl-per-hydro-benz[e]inden i form av en lysegul harpiks. En opplosning av dette råprodukt i 100 ml etanol ble hydrogenert under normaltrykk og ved romtemperatur i nærvær av 2,5 g kaliumhydrok- A solution of 1.308 g of (+)-trans-anti-6-[(3,5-dimethylisoxazol-4-yl)-methyl]-3a-methyl-3,7-dioxo-1,2,3a,4, 5,7,8,9,9a,9b-decahydro-3H-benz[e]indene in 100 ml of a 3:1 mixture of ethanol and triethylamine was hydrogenated at room temperature and under atmospheric pressure in the presence of 80 mg of palladium on charcoal ( 10%). The hydrogen absorption stopped after 1 1/2 hours. Filtration and removal of the solvent gave trans-anti-trans-6-[(3,5-dimethyl-isoxazol-4-yl)-methyl]-3a-methyl-3,7-dioxo-perhydro-! benz[e]inden as foamless foam. This crude product was taken up in 10 ml of ethylene glycol and 75 ml of petroleum ether (petrol) and heated for 20 hours with 750 mg of p-toluenesulfonic acid under reflux cooling and a nitrogen atmosphere by azeotropic removal of water. The cooled solution was washed with saturated aqueous sodium bicarbonate solution and brine, dried over anhydrous sodium sulfate and concentrated to give trans-anti-trans-3,3,7,7-bis-(ethylenedioxy)-6-[(3,5 -dimethylisoxazol-4-yl)-methyl]-3a-methyl-per-hydro-benz[e]indene in the form of a pale yellow resin. A solution of this crude product in 100 ml of ethanol was hydrogenated under normal pressure and at room temperature in the presence of 2.5 g of potassium hydroxide

syd og 100 mg palladium på kull (10 %). I lopet av 5 timer ble én ekvivalent hydrogen tatt opp. Katalysatoren ble fjernet ved filtrering og filtratet konsentrert til ca. 5 ml. Til denne opplosning av det vinyloge amid ble tilsatt 150 ml av en 20%'s vandig kaliumhydroksydopploshing. Blandingen ble avgasset, syd and 100 mg of palladium on charcoal (10%). In the course of 5 hours, one equivalent of hydrogen was taken up. The catalyst was removed by filtration and the filtrate concentrated to approx. 5 ml. To this solution of the vinylogous amide was added 150 ml of a 20% aqueous potassium hydroxide solution. The mixture was degassed,

satt under nitrogen, oppvarmet 16 timer under nitrogenatmos-placed under nitrogen, heated 16 hours under a nitrogen atmosphere

fære til tilbakelop, avkjolt og ekstrahert med benzen. Benzenopplosningen ble vasket med koksaltopplosning og torket over vannfritt natriumsulfat. Fjerning av opplosningsmidlet ga trans-anti-trans-bis-(etylendioksy)-3a-metyl-6-(3-oksobutyl)-perhydrobenz[e]inden i form av en farvelos harpiks. Dette materiale ble tatt opp i 50 ml metanol, avgasset og satt un- brought to reflux, cooled and extracted with benzene. The benzene solution was washed with sodium chloride solution and dried over anhydrous sodium sulfate. Removal of the solvent gave trans-anti-trans-bis-(ethylenedioxy)-3α-methyl-6-(3-oxobutyl)-perhydrobenz[e]indene as a colorless resin. This material was taken up in 50 ml of methanol, degassed and set aside

der nitrogen. Etter tilsetning av 5 ml 4 N saltsyre ble blandingen oppvarmet i 3 timer under tilbakelopskjoling, avkjolt, fortynnet med vann og ekstrahert med benzen. Benzenopplosningen ble vasket med vann, mettet vandig natriumbikarbonatopplosning og koksaltopplosning og torket over vannfritt natriumsulfat. where nitrogen. After addition of 5 ml of 4 N hydrochloric acid, the mixture was heated for 3 hours under reflux, cooled, diluted with water and extracted with benzene. The benzene solution was washed with water, saturated aqueous sodium bicarbonate solution and sodium bicarbonate solution and dried over anhydrous sodium sulfate.

Etter fjerning av opplosningsmidlet ble rått (+)-19-nor-androst-4-en-3,17-dion oppnådd, som ble renset over silikagel med benzen-eter (9:1) og ved krystallisasjon fra aceton-heksan; smp. 173-174°. After removal of the solvent, crude (+)-19-nor-androst-4-ene-3,17-dione was obtained, which was purified over silica gel with benzene-ether (9:1) and by crystallization from acetone-hexane; m.p. 173-174°.

EKSEMPEL 3EXAMPLE 3

En opplosning av 11,35 g racemisk trans-anti-3a-etyl-6-[(3,5-dimetyl-isoksazol-4-yl) -metyl]-3 , 7-diokso-l., 2, 3a, 4 , 5 , 7 ,8 , 9, 9a, 9b-dekahydro-3H-benz[e]inden i 300 ml absolutt etan og 100 ml trietylamin ble i nærvær av 500 mg palladium på kull (5 %) hydrogenert ved romtemperatur og under normaltrykk. Etter 2 timer var hydrogenopptagelsen fullfort. Katalysatoren ble fjernet ved filtrering og vasket med frisk etanol. Etter fjerning av opplosningsmidlet under redusert trykk (til sist ved 50° A solution of 11.35 g of racemic trans-anti-3a-ethyl-6-[(3,5-dimethyl-isoxazol-4-yl)-methyl]-3,7-dioxo-l.,2,3a,4 , 5 , 7 ,8 , 9, 9a, 9b-decahydro-3H-benz[e]indene in 300 ml absolute ethane and 100 ml triethylamine was hydrogenated in the presence of 500 mg palladium on charcoal (5%) at room temperature and under normal pressure . After 2 hours, hydrogen uptake was complete. The catalyst was removed by filtration and washed with fresh ethanol. After removal of the solvent under reduced pressure (finally at 50°

og 0,01 mm for å fjerne de siste spor av trietylamin) ble racemisk trans-anti-trans-3a-etyl-6-[(3,5-dimetyl-isoksazol-4-yl)-metyl]-3,7-diokso-perhydro-benz[e]inden oppnådd i form av hvite nåler, smp. 143,5 - 146° (fra metylenklorid-eter). and 0.01 mm to remove the last traces of triethylamine) became racemic trans-anti-trans-3α-ethyl-6-[(3,5-dimethyl-isoxazol-4-yl)-methyl]-3,7- dioxo-perhydro-benz[e]indene obtained in the form of white needles, m.p. 143.5 - 146° (from methylene chloride-ether).

Claims (4)

1. Fremgangsmåte for fremstilling av perhydrobenzindener av formelen1. Process for the preparation of perhydrobenzindenes of the formula hvor R"*" betyr en primær alkylgruppe med 1-5 C-atomer, R og R er like og betyr alkyl med 1-8 C-atomer eller en rest av begge hydrogen og den andre alkyl med 1-8 C-atomer, og Z er karbonyl, C1 _g-alkylendioksy-metylen, di-C1 _g-alkoksymetylen, fendioksy-metylen eller en gruppe av formel en where R"*" means a primary alkyl group with 1-5 C atoms, R and R are the same and mean alkyl of 1-8 C atoms or a residue of both hydrogen and the other alkyl of 1-8 C atoms, and Z is carbonyl, C 1 -g -alkylenedioxymethylene, di-C 1 -g -alkoxymethylene, phendioxymethylene or a group of formula one j hvor R er hydrogen, C1 _g-alkyl, C1 _g-alkoksy-C1 _g- j alkyl, fenyl-C^ _g-alkyl, tetrahydropyranyl eller en acylrest av en C-^ g-monokarboksylsyre, R hydrogen eller en alifatisk hydrokarbongruppe med 1-8 C- atomer og m er 1 eller 2, karakterisert ved at man hydrogenerer en forbindelse av formelen j where R is hydrogen, C1 _g-alkyl, C1 _g- alkoxy-C1 _g- j alkyl, phenyl-C1-6-alkyl, tetrahydropyranyl or an acyl residue of a C-^ g-monocarboxylic acid, R hydrogen or an aliphatic hydrocarbon group with 1-8 C- atoms and m is 1 or 2, characterized by hydrogenating a compound of the formula i nærvær av en edelmetalkatalysator, i noytralt, surt eller svakt basisk miljo. in the presence of a noble metal catalyst, in a neutral, acidic or weakly basic environment. 2. Fremgangsmåte etter kravl, karakterisert ved at hydrogeneringen gjennomfores i et inert organisk opplosningsmiddel ved romtemperatur og under normaltrykk. 2. Procedure after crawling, characterized in that the hydrogenation is carried out in an inert organic solvent at room temperature and under normal pressure. 3. Fremgangsmåte etter kravene 1 og 2, karakterisert ved at som katalysator anvendes palladium. 3. Method according to claims 1 and 2, characterized in that palladium is used as catalyst. 4. Fremgangsmåte etter kravene 1-3, karakterisert ved at reaksjonsmediet inneholder et mono-, di- eller tri-lavere-alkylamin.4. Method according to claims 1-3, characterized in that the reaction medium contains a mono-, di- or tri-lower alkylamine.
NO751208A 1968-11-22 1975-04-08 NO751208L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77831468A 1968-11-22 1968-11-22
NO4629/69A NO133806C (en) 1968-11-22 1969-11-21

Publications (1)

Publication Number Publication Date
NO751208L true NO751208L (en) 1970-05-23

Family

ID=26647546

Family Applications (1)

Application Number Title Priority Date Filing Date
NO751208A NO751208L (en) 1968-11-22 1975-04-08

Country Status (1)

Country Link
NO (1) NO751208L (en)

Similar Documents

Publication Publication Date Title
NO133806B (en)
US2542223A (en) 6-keto-delta-10-methyldecalone-1
US4044004A (en) Total steroid synthesis employing substituted isoxazole derivatives
Baltzly et al. Synthetic Analogs of Oxytocic Drugs. I. Phenethyl β-Alanine Derivatives
GB2086907A (en) Corticoid synthesis via new steroid 17-spiro-oxazolines
US2970147A (en) 3-hydroxy-nu-(heterocyclic-ethyl)-morphinans
IE861233L (en) 17-alpha-ethynyl steroid
US3781311A (en) Novel preparation of trienic steroids
US2606197A (en) Halosteroid acid derivatives and preparation of same
US2562194A (en) Aminomethyl-keto-steroids and process of preparing
US3272801A (en) Steroidal spiro-oxazolidinones
US3439022A (en) Methylene-substituted-a-norgonanes
US3337542A (en) 2-alkyl-2-[(optionally-substituted) amino-1-naphthyliden]ethylcyclopentane -1, 3-diones, 3-(optionallysubstituted)amino-14-hydroxyestratetraen-17-ones corresponding and derivatives thereof
US3080399A (en) Cyclopentanophenanthrene compounds and process
US3118915A (en) 2alpha-lower alkyl dihydro testosterone and derivatives thereof
US3359282A (en) -3-oxa-5alpha-androstan-17beta-ols, esters corresponding and intermediates thereto
US3407219A (en) 17alpha-alkyl-17beta-methyl-8xi, 9xi, 13xi, 14xi-gona-1,3,5(10)-trien-3-ols and conge
US3985771A (en) Total steroid synthesis employing substituted isoxazole derivatives
US2734907A (en) Process for the production of
US4582644A (en) Epi-ethynylation process
US3856864A (en) Synthesis of a-ring aromatic steroids
US3145200A (en) Steroido[3.2-c]isoxazoles and preparation thereof
US3984428A (en) Isoxazolyl-substituted perhydrobenzindenes
US2791585A (en) Steroid alpha-halo ketals
US3455907A (en) Process and intermediates for the manufacture of 3-keto-17-ketal steroids